FindTrial
Sign In

How does Vitamin D help in anaemic patients suffering from ulcerative colitis

Role of Vitamin D as an add on therapy in ulcerative colitis patients with anaemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035128
Enrollment
60
Registered
2021-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D53- Nutritional anemias Health Condition 2: K51- Ulcerative colitis

Interventions

Intervention1: Vitamin D and mesalamine and prednisolone for 3 months: Oral Vitamin D 4000 IU and mesalamine 2.4 - 3.6 g/day and prednisolone 40mg/day for 3 months Control Intervention1: Mesalamine an

Sponsors

Pandit B D Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to provide informed consent, Patients with Mayo score Patients with haemoglobin between 8-11g/dl

Exclusion criteria

Exclusion criteria: Severe systemic disease, Other disorders which mimic UC symptoms, Pregnant & lactating females, Previous gastrointestinal surgery, Study drugs related allergic reaction

Design outcomes

Primary

MeasureTime frame
Remission of ulcerative colitis Abdominal pain Haemoglobin levelsTimepoint: Remission of ulcerative colitis at baseline, 12 weeks Abdominal pain at baseline, 4 weeks, 8 weeks, 12 weeks Haemoglobin levels at baseline and 12 weeks—

Secondary

MeasureTime frame
Quality of life Intestinal inflammationTimepoint: 0 months & 3 months—

Countries

India

Contacts

Public ContactDr Komal Dalal

PGIMS, Rohtak, India

Komal.dalal99@gmail.com8901272052

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026